To raise awareness of the importance of equitable and high-quality cancer screening programmes across Europe, a short informative video has been produced about the European Union (EU) co-funded project “Joint Action on Implementation of Cancer Screening Programmes” (EUCanScreen), coordinated by the University of Latvia (LU). The video provides an overview of the project’s objectives, the importance of cross-country collaboration, and the public health benefits it aims to deliver.

EUCanScreen is a large-scale European project that seeks to ensure sustainable, high-quality, cost-effective and accessible cancer screening programmes for all citizens. The project covers existing screening areas – breast, cervical and colorectal cancer screening – while also assessing the potential introduction of lung, prostate and gastric cancer screening programmes across Europe.
The project involves 29 countries, including 25 EU Member States as well as Ukraine, Moldova, Norway and Iceland. EUCanScreen has a four-year implementation period and has already been actively underway for approximately a year and a half.
At its core, the project is based on collaboration and knowledge exchange between countries, with the aim of strengthening existing screening programmes and exploring opportunities to introduce new ones. “That’s the whole idea behind the project – to bring all the countries together, so that countries that are struggling currently with their existing programmes can learn from the countries that have organised it in a different manner and have experience in how to do it well,” emphasises Iris Lansdrop-Vogelaar from Erasmus University Medical Center in the Netherlands.
The project brings together experts from different levels and fields, thereby strengthening its overall impact and cooperation. “It’s unique that we have so many countries together from every layer. So not just the people that organise the screening, but also the health policy makers, the ministries. And there, I think with all of those people together in one room like we have now, that can really change,” adds I. Lansdrop-Vogelaar.
The project’s Scientific Coordinator, Professor Mārcis Leja, points out: “Screening programmes are expected to be changing in the future. Programmes might be becoming individualised based on the results of the previous screening test, the characteristics of the person, and maybe even genetics.” This highlights that the project is not only focused on harmonising cancer screening programmes across Europe, but also on promoting more innovative and personalised approaches to cancer diagnostics in order to improve healthcare for populations throughout Europe.

To watch the video, please click here: https://youtu.be/zxabMeh0c24?si=vtEobdE_C3Uf83L3

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
 

Share